Published in J Clin Endocrinol Metab on May 19, 2010
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
The TSH upper reference limit: where are we at? Nat Rev Endocrinol (2011) 0.90
The thyroid gland and the process of aging; what is new? Thyroid Res (2012) 0.83
Total and free thyroxine and triiodothyronine: measurement discrepancies, particularly in inpatients. Clin Biochem (2014) 0.81
Gender-specific regulation of response to thyroid hormone in aging. Thyroid Res (2012) 0.81
Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment. Front Endocrinol (Lausanne) (2015) 0.80
Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol (2013) 0.79
Clinical evaluation of various thyroid hormones on thyroid function. Int J Endocrinol (2014) 0.77
TSH Measurement and Its Implications for Personalised Clinical Decision-Making. J Thyroid Res (2012) 0.76
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc (1985) 7.02
Thyroid status, disability and cognitive function, and survival in old age. JAMA (2004) 5.39
Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab (2007) 2.48
Changes in renal function in primary hypothyroidism. Am J Kidney Dis (1996) 1.71
Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med (1999) 1.63
Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc (1994) 1.57
Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab (2009) 1.44
Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med (1982) 1.41
Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am (1990) 1.33
The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab (1990) 1.23
Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis (1990) 1.17
Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta (2008) 1.16
Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med (1983) 1.13
Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab (1993) 1.11
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. J Nucl Med (2006) 1.10
Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism (1974) 1.08
Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol (1977) 1.07
Sex and age differences in levothyroxine dosage requirement. Endocr Pract (2010) 1.03
Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer. J Clin Endocrinol Metab (1980) 0.99
Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol (2003) 0.98
Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer. J Clin Endocrinol Metab (2004) 0.94
Lean body mass is a predictor of the daily requirement for thyroid hormone in older men and women. J Am Geriatr Soc (1984) 0.93
Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer. Endocr Pract (2008) 0.91
Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab (1980) 0.90
Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma. Arch Med Res (2002) 0.88
Preparation for radioactive iodine administration in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) (2002) 0.88
Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma. J Nucl Med (1979) 0.87
Three-week thyroxine withdrawal: a thyroid-specific quality of life study. Laryngoscope (2006) 0.86
Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus. Endocr Pract (2005) 0.84
Differences in the metabolic clearance of pituitary and serum thyrotropin (TSH) derived from euthyroid and hypothyroid rats: effects of chemical deglycosylation of pituitary TSH. Endocrinology (1986) 0.84
Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. J Clin Endocrinol Metab (2005) 0.83
Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation. J Nucl Med (2004) 0.83
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma. J Endocrinol Invest (2003) 0.83
Functional central hypothyroidism in the elderly. Aging Clin Exp Res (2008) 0.82
Age modifies the pituitary TSH response to thyroid failure. Thyroid (2007) 0.80
The effect of age on serum creatinine levels in an aging population: relevance to vascular surgery. Cardiovasc Surg (2002) 0.80
The effects of the duration of severe hypothyroidism and aging on the metabolic clearance rate of thyrotropin (TSH) and the pituitary TSH response to TSH-releasing hormone. Endocrinology (1984) 0.80
Lithium toxicity precipitated by profound hypothyroidism. Thyroid (2008) 0.79
Age and the daily dose of thyroxine replacement therapy for hypothyroidism. Age Ageing (1984) 0.79
Age, sex, and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol (Copenh) (1991) 0.79
Age-related alterations in pulsatile secretion of TSH: role of dopaminergic regulation. Am J Physiol (1991) 0.78
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
Thyroid Nodules. N Engl J Med (2015) 2.65
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J Nucl Med (2012) 2.08
Quality of interventional radiology literature: a review of articles published in JVIR and CVIR. J Vasc Interv Radiol (2009) 1.71
Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid (2010) 1.65
Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54
A 2011 survey of clinical practice patterns in the management of Graves' disease. J Clin Endocrinol Metab (2012) 1.43
Subclinical hyperthyroidism: controversies in management. Am Fam Physician (2002) 1.42
Bilateral versus unilateral femoral access for uterine artery embolization: results of a randomized comparative trial. J Vasc Interv Radiol (2010) 1.42
Recurrence after treatment of micropapillary thyroid cancer. Thyroid (2009) 1.41
Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab (2009) 1.36
The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta (2005) 1.32
Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid (2007) 1.25
Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab (2005) 1.24
Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab (2002) 1.24
Clinical review: Ectopic cervical thyroid carcinoma--review of the literature with illustrative case series. J Clin Endocrinol Metab (2011) 1.21
The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab (2004) 1.20
Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid (2008) 1.18
Akt1 contains a functional leucine-rich nuclear export sequence. Biochem Biophys Res Commun (2005) 1.15
Hypothyroidism. Endocrinol Metab Clin North Am (2007) 1.14
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. Thyroid (2013) 1.12
Myxedema coma. J Intensive Care Med (2007) 1.12
The glucocorticoid agonist activities of mifepristone (RU486) and progesterone are dependent on glucocorticoid receptor levels but not on EC50 values. Steroids (2007) 1.08
Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid (2011) 1.07
The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid (2009) 1.07
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab (2013) 1.05
Radioiodine therapy in patients with stage I differentiated thyroid cancer. Thyroid (2010) 1.04
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. Thyroid (2010) 1.03
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol Head Neck Surg (2005) 1.02
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? Clin Endocrinol (Oxf) (2011) 1.01
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab (2005) 0.98
Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2005) 0.98
Use of steroid profiles in determining the cause of adrenal insufficiency. Steroids (2006) 0.97
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocr Relat Cancer (2012) 0.96
17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J Clin Endocrinol Metab (2004) 0.95
Thyroid nodules. Med Clin North Am (2012) 0.94
Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome. Thyroid (2009) 0.92
Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid (2013) 0.91
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid (2012) 0.90
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Mol Carcinog (2004) 0.90
Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis. Thyroid (2005) 0.90
Metastases of well-differentiated thyroid cancer to the gastrointestinal system. Thyroid (2010) 0.89
Thyroid disorders in pregnancy. Endocrinol Metab Clin North Am (2011) 0.87
Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. Thyroid (2014) 0.86
Weight changes in euthyroid patients undergoing thyroidectomy. Thyroid (2011) 0.86
Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters. Ther Drug Monit (2015) 0.86
Current treatment modalities for spinal metastases secondary to thyroid carcinoma. Thyroid (2014) 0.85
Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes? AJR Am J Roentgenol (2002) 0.85
Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab (2002) 0.84
Micropapillary thyroid cancer: should we aspirate all nodules regardless of size? J Clin Endocrinol Metab (2006) 0.84
Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking. Thyroid (2005) 0.83
Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. J Thyroid Res (2011) 0.83
The effect of medications on thyroid function tests. Med Clin North Am (2012) 0.83
Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer. J Clin Endocrinol Metab (2011) 0.83
A 2013 survey of clinical practice patterns in the management of primary hypothyroidism. J Clin Endocrinol Metab (2014) 0.82
Two cases of statin-induced myopathy caused by induced hypothyroidism. Endocr Pract (2008) 0.80
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. J Endocrinol (2012) 0.80
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. Endocr Pract (2013) 0.80
Ectopic intratracheal thyroid: an illustrative case report and literature review. Thyroid (2005) 0.79
Thyrotoxicosis-induced ventricular arrhythmias. Thyroid (2008) 0.79
Overt and 'subclinical' hypothyroidism in women. Obstet Gynecol Surv (2006) 0.79
Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice. Thyroid (2013) 0.78
Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer. Thyroid (2008) 0.78
Agreement of immunoassay and tandem mass spectrometry in the analysis of cortisol and free t4: interpretation and implications for clinicians. Int J Anal Chem (2010) 0.78
Age modifies the response to recombinant human thyrotropin. Thyroid (2010) 0.78
Salivary gland malignancy and radioiodine therapy for thyroid cancer. Thyroid (2010) 0.78
Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma. Thyroid (2009) 0.78
Differences in SPET analysis of thyroid-associated orbitopathy. Eur J Nucl Med Mol Imaging (2004) 0.78
Human papillomavirus seroprevalence among men entering military service and seroincidence after ten years of service. MSMR (2013) 0.78
Thyroid medications during pregnancy. Ther Drug Monit (2006) 0.77
Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options. J Clin Endocrinol Metab (2012) 0.77
Pediatric acute lymphoblastic leukemia and exposure to pesticides. Ther Drug Monit (2009) 0.77
Thyroid cancer molecular signaling pathways and use of targeted therapy. Endocrinol Metab Clin North Am (2007) 0.77
Hypocortisolemia in Graves hyperthyroidism. Endocr Pract (2009) 0.77
Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol (2011) 0.77
Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism. Thyroid (2005) 0.76
Thyroid function: Gestational hypothyroidism--a need for universal screening? Nat Rev Endocrinol (2012) 0.76
Variability in reporting fine-needle aspirations of thyroid. Thyroid (2010) 0.75
Repositioning therapy for thyroid cancer: new insights on established medications. Endocr Relat Cancer (2014) 0.75
Thyroid Nodules. N Engl J Med (2016) 0.75
Treatment of hypothyroidism: possibilities on the horizon. Thyroid (2013) 0.75
A new paradigm in the treatment of carcinoma: specific molecular targeting. Endocrinology (2004) 0.75
Autoimmune thyroid disease and chronic urticaria. Clin Endocrinol (Oxf) (2007) 0.75
The EUROPA trial. Lancet (2003) 0.75
Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy. Thyroid (2009) 0.75
Intravenous methimazole in the treatment of refractory hyperthyroidism. Thyroid (2006) 0.75
Thyroid disorders and diseases. Med Clin North Am (2012) 0.75
18F- FDG-PET SUV as a Prognostic Marker of Increasing Size in Thyroid Cancer Tumors. Endocr Pract (2016) 0.75
WHAT IS THE CLINICAL ROLE OF ORAL LIQUID PREPARATIONS IN THE TREATMENT OF PATIENTS WITH HYPOTHYROIDISM? Endocr Pract (2017) 0.75